Occudo Quantitative Strategies LP Humanigen, Inc Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.76 - $3.33 $8,194 - $15,504
-4,656 Reduced 3.95%
113,359 $201,000
Q1 2022

May 16, 2022
SELL
$1.81 - $3.97 $8,838 - $19,385
-4,883 Reduced 3.97%
118,015 $355,000
Q4 2021

Feb 14, 2022
BUY
$3.66 - $8.22 $387,883 - $871,147
105,979 Added 626.39%
122,898 $457,000
Q3 2021

Nov 15, 2021
BUY
$5.93 - $17.83 $100,329 - $301,665
16,919 New
16,919 $100,000

Others Institutions Holding HGEN

# of Institutions
4
Shares Held
558K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email